Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02547168 : Determining the True Incidence of Atrial Fibrillation Before and After Lung Resection
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Patients must be at least 18 years of age and competent to consent

- Patients must be diagnosed with resectable lung cancer or metastatic lung disease
eligible to complete metastasectomy

- Patients must have one of: Male gender, age greater than 65, hypertension, obesity,
and recent tobacco use within the past year

- Patients must be booked for pneumonectomy, lobectomy or anatomical segmentectomy

Exclusion Criteria:

- Patients undergoing emergent lung resection

- Patients undergoing lung resection for non-oncologic indications (lung biopsy,

- Patients with an existing neurostimulator

- Patients with pre-existing cardiac disease, defined as:

- Patients with atrioventricular blockage of any degree or sick sinus syndrome;

- Patients with known previous atrial fibrillation or flutter lasting more than 1

- Patients with any persistent diagnosed preoperative arrhythmia

- Patients with implanted external defibrillators or pacemakers

- Patients with known adhesive allergies

- Inability to comply with or understand ambulatory monitoring.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557